Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Humanigen, Inc.
Age
16–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of asthma established for at least 2 years
Symptomatic asthma as defined by the Juniper Asthma Control Questionnaire
Symptomatic asthma despite stable treatment with inhaled corticosteroids fluticasone or budesonide, or other corticosteroids, for at least 12 weeks
Currently receiving inhaled long-acting beta agonist (LABA) or previously documented LABA intolerability or lack of responsiveness
At least 2 exacerbations (no more than 6) in the previous 12 months that required systemic corticosteroids or at least a doubling of daily oral dose
You may not be if
Acute asthma worsening (requiring emergency room visit, hospitalization, urgent care, physician visit, or change in asthma medications) or lower respiratory tract infection requiring the use of antibiotics, within 4 weeks prior to Screening Visit.
History of life-threatening asthma with admission to the intensive care unit requiring the use of mechanical ventilation within the past 12 months
Use of any immunosuppressive or immunomodulatory agents within 12 weeks or an investigational agent within 4 weeks prior to Screening Visit
History of any cardiovascular, neurological, hepatic, or renal condition
History of smoking within the past 12 months
Clareo Health | Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
